These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3009557)

  • 1. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK; Moore M; Harris M
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
    Candlish W; Kerr IB; Simpson HW
    J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
    Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
    Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoperoxidase localization of lactalbumin in malignant breast neoplasms.
    Clayton F; Ordóñez NG; Hanssen GM; Hanssen H
    Arch Pathol Lab Med; 1982 Jun; 106(6):268-70. PubMed ID: 6284085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas.
    Gabius HJ; Brehler R; Schauer A; Cramer F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):107-15. PubMed ID: 2878527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.
    Thor A; Ohuchi N; Hand PH; Callahan R; Weeks MO; Theillet C; Lidereau R; Escot C; Page DL; Vilasi V
    Lab Invest; 1986 Dec; 55(6):603-15. PubMed ID: 2431221
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.
    Lundy J; Grimson R; Mishriki Y; Chao S; Oravez S; Fromowitz F; Viola MV
    J Clin Oncol; 1986 Sep; 4(9):1321-5. PubMed ID: 3528401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
    Sappino AP; Skalli O; Jackson B; Schürch W; Gabbiani G
    Int J Cancer; 1988 May; 41(5):707-12. PubMed ID: 2835323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue.
    Dairkee SH; Puett L; Hackett AJ
    J Natl Cancer Inst; 1988 Jul; 80(9):691-5. PubMed ID: 2453676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprecipitation of cell lysates with RAP-5 does not specifically detect ras oncogene product p21.
    Gutheil JC; Mane S; Kapil V; Needleman SW
    Hum Pathol; 1989 Dec; 20(12):1176-80. PubMed ID: 2687155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of ras proto-oncogene related protein p21 in normal human skin and cutaneous tumours.
    Tanikawa E; Mori O; Hachisuka H; Sasai Y
    Acta Histochem; 1992; 93(1):282-9. PubMed ID: 1326835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
    Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
    J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.